In March 2024, the below number of individuals have been recruited in Swedegene. DNA and clinical data collection for these are completed.

ADR type	Number
Angioedema	549
Anaphylaxis	158
Urticaria	209
Other allergic reactions	122
Cough related to ACE-inhibitors	153
Osteonecrosis and atypical fractures due to bisphosphonates	151
Phototoxic reactions (mainly due to topical NSAIDs)	53
Blood cell dyscrasia (agranulocytosis, thrombocytopenia and anemia) to non-cytostatic drugs	327
Metabolic reactions from neuroleptics and antidepressants (mainly weight gain)	73
Hyponatremia/SIADH due to antidepressants and antiepileptics	39
CNS toxicity and neuropsychiatric reactions from antiviral therapy and antibiotics	97
Stevens-Johnson syndrome/Toxic epidermal necrolysis	69
Tendon-rupture from flouroquinolones	34
Liver toxicity	530
Rhabdomyolysis related to statins/fibrates	57
Torsade de Pointes/QT-prolongation	35
Narcolepsy associated with Pandemrix	85
Hypersomnia associated with Pandemrix	14
Pancreatitis	102
Alopecia	28
Bleedings from new oral anticoagulants (NOACs)	169
Lack of efficacy of NOACs	33
Pneumonitis	47
Renal toxicity	109
Ankle oedema from calcium channel blockers	54
Gingival hyperplasia from calcium channel blockers	17
Adverse reactions to Covid-19 vaccines	931
Thyroiditis	17
Gastrointestinal reactions to medication for Parkinson’s disease	2
Controls	590
Total number of cases	4565

ACE = angiotensin converting enzyme; NSAID = non-steroidal anti-inflammatory drug; NOAC=non-vitamin K oral anticoagulant drug.

Note that the number of cases for a particular ADR may be greater than the total number of cases as some individuals have experienced multiple ADRs concomitantly.